The global clinical trial analytics market size is expected to reach USD 17.06 Billion in 2032 and is expected to register steady revenue CAGR of 13.4% during the forecast period, according to the latest analysis by Emergen Research. Increasing cost of conducting clinical trials is a key factor driving revenue growth of the market. Clinical studies are expensive, and this has a negative effect on

0
Comments